Alpha Win Capital
VC Fund
Sheung Wan, Hong Kong
Alpha Win Capital is a company that deals in securities, advising on securities, and asset management.The company is engaged in various types of securities brokerage businesses, including securities brokerage, primary market underwriting, and placement, secondary market securities trading, and bonds, which are all regulated by SFC.It wasfounded in Sheung Wan, Hong Kong.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Alpha Win Capital invests in
Stages Alpha Win Capital invests in
Countries Alpha Win Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Peak Wang
|
|||
Investment Focus
Industry
- Biotechnology 2 (100%)
- Biopharma 1 (50%)
- Health Care 1 (50%)
- Therapeutics 1 (50%)
- Medical Device 1 (50%)
Stage
- Series B 1 (50%)
- Series D 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Peak Wang
Founder, Partner & Managing Director
|
Founder, Partner & Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Treadwell Therapeutics
|
Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer. Founded by a cadre of pre-eminent scientific luminaries, including Dr. Tak W. Mak, the Company's robust, internally developed pipeline includes a first-in-class PLK4 kinase inhibitor, CFI-400945, and abest-in-class TTK inhibitor, CFI-402257, and CFI-402411, an oral immunomodulatory kinase inhibitor with activity toward HPK1. Treadwell also has a robust pre-clinical pipeline with multiple biologic and next-generation TCR-based autologous cell therapy programs. | $91M / Series B / Nov 18, 2021 | |
Sirnaomics
|
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology. | $105M / Series D / Oct 23, 2020 |
Co-Investors
Longmen Capital
1 deal together
Prosperous Alliance Investments
1 deal together
RiverHead Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Alpha Win Capital invest in?
Alpha Win Capital invests primarily in Biotechnology, Biopharma and Health Care startups, most often at Series B and Series D stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alpha Win Capital?
Public channels for Alpha Win Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Alpha Win Capital?
The team at Alpha Win Capital includes Peak Wang (Founder, Partner & Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
